Comparing the outcome of surgery in total robotic hysterectomy: traditional vs ERAS pathway
Not Applicable
- Conditions
- Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patients aged 30-60 years undergoing Robotic hysterectomy for benign indication
2)Patient who are willing and give consent
Exclusion Criteria
1)Patient not willing to participate in the study
2)Contraindications for neuraxial anesthesia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine if ERAS pathways in robotic hysterectomy shortens the length of hospital stay in days. <br/ ><br>1. Fit for discharge in days <br/ ><br>2. Time to tolerate of diet in days <br/ ><br>3. Time to flatus / defecation in days <br/ ><br>Timepoint: <br/ ><br>1. Post operative complications within 30 days <br/ ><br>2. Quality of life on post-op day 2 and after 30 days of surgery <br/ ><br>3. Readmission rates within 30 days
- Secondary Outcome Measures
Name Time Method To evaluate the efficacy of ERAS protocol in: <br/ ><br>1. Reducing Postoperative complications <br/ ><br>2. Reducing readmissions rate <br/ ><br>3. Reduction in time to tolerance of diet <br/ ><br>4. Reduction in time to passage of flatus/defecation. <br/ ><br>5. Patient satisfaction and the quality of life and its psychological impact. <br/ ><br>Timepoint: �?Readmission rate within 30 days of discharge <br/ ><br>�?Quality Of Life by WHO-QOL BREF(Annexure VIII) <br/ ><br>Patient will be followed up at Post-operative Day 2 and Day 30 considering the day of surgery as Day 0. <br/ ><br>